ASCO GU 2019: Clinically Meaningful Antitumor Activity of Nivolumab Monotherapy Observed for the First Time in Non-Clear Cell Renal Cell Carcinoma
Responses were observed in several histological subtypes.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.